About TG THERAPEUTICS INC
TG Therapeutics is a biopharmaceutical company focused on the development and commercialization of innovative therapies for multiple sclerosis (MS). The company's product, BRIUMVI (ublituximab), is approved by the U.S. FDA for the treatment of relapsing forms of MS.
Development of monoclonal antibody therapiesClinical trials and research in multiple sclerosisCommercialization of FDA-approved MS treatments
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to TG THERAPEUTICS INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.